Clinical Assessment of Risk Factors for the Intracerebral Hemorrhage in Patients with Chronic Renal Failure

다국어 초록 (Multilingual Abstract)

Objective : Cerebrovascular and cardiovacular diseases are the main causes of death in patients with chronic renal failure (CRF) and who are undergoing hemodialysis. We investigated the risk factors for the development of intracerbral hemorrhage (ICH) in this population. Methods : We retrospectively reviewed a total of 53 patients who underwent hemodialysis for CRF and who developed ICH. The patients?demographics, including gender and age, the duration of the hemodialysis, the initial Glasgow Coma Scale (GCS) score, the underlying causes of CRF, the past medication history, the location and amount of hemorrhage and the therapeutic modality for ICH were analyzed. Results : The development of ICH significantly increased in the old age patients (≥ 65 years), the patients with a prolonged history of hemodialysis (≥ 5 years) and the patients with hypertension (p < 0.05). However, gender, anemia (hemoglobin ≤ 8.0 g/dl) and the initial systolic blood pressure (≥ 180 mmHg) were not significantly correlated with the occurrence of intracerebral hemorrhage in the hemodialyzed patients. Conclusion : The present study suggests that the development of ICH in patients with CRF is increased in the old age patients, the patients with a prolonged history of hemodialysis and the medically co-morbid patients. To avoid this disastrous complication, we should try to minimize the modifiable risk factors of hemorrhagic stroke in CRF patients. (Kor J Cerebrovascular Surgery 12(2):70-75, 2010)

참고문헌 (Reference)

1 Higashida RT, "intracranial aneurysms: interventional neurovascular treatment with detachable balloons--results in 215 cases" 178 : 663-670, 1991

2 The International Study of Unruptured Intracranial Aneurysms Investigators, "Unruptured intracranial aneurysms?risk of rupture and risks of surgical intervention" 339 : 1725-1733, 1998

3 Fiorella D., "US multicenter Experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results" 38 : 881-887, 2007

4 Higashida RT, "Treatment of unruptured intracranial aneurysms: a nationwide assessment of effectiveness" 28 : 146-151, 2007

5 Raja AI, "Time-line for the treatment of cerebral AVMS : surgery" 53 : 552-553, 2000

6 Ondra SL, "The natural history of symptomatic arteriovenous malformations of the brain : a 24-year follow-up assessment" 73 : 387-391, 1990

7 Feigin VL, "Stroke epidemiology a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century" 2 : 43-53, 2003

8 Byun HS, "Status quo of cerebral aneurysm management in Korea : Comparison between endovascular embolization and microsurgical clipping" 4 : 1-5, 2009

9 Iso H., "Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the Multiple Risk Factor Intervention Trial" 320 : 904-910, 1989

10 Hartmann A., "Risk of endovascular treatment of brain arteriovenous malformations" 33 : 1816-1820, 2002

11 Hyun-Seok Park, "Recent Epidemiological Trends of Stroke" 대한신경외과학회 43 (43): 16-20, 2008

12 Kim LJ, "Postembolization neurological deficits in cerebral arteriovenous malformations: stratification by arteriovenous malformation grade" 59 : 53-59, 2006

13 Ueda K., "Intracerebral hemorrhage in a Japanese community, Hisayama: incidence, changing pattern during long-term follow-up, and related factors" 19 : 48-52, 1988

14 Bhatt DL, "Hacke W, Berger PB, Black HR, Boden WE, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombtic events" 354 : 1706-1717, 2006

15 Korean Neurology Association, "Epidemiology of cerebrovascular disease in Korea" 8 : 281-289, 1993

16 Pandey AS, "Endovascular coil embolization of ruptured and unruptured posterior circulation aneurysms: review of a 10-year experience" 60 : 626-636, 2007

17 Meisel HJ, "Effect of partial targeted N-butyl-cyano-acrylate embolization in brain AVM" 144 : 879-887, 2002

18 "Eastern Stroke and Coronary Heart Disease Collaborative Research Group Blood pressure, cholesterol, and stroke in eastern Asia" 352 : 1801-1807, 1998

19 Young Il Jeon, "Current Status and Future Prospect of Endovascular Neurosurgery" 대한신경외과학회 43 (43): 69-78, 2008

20 Park KW, "Cost analysis for the management of cerebral aneurysms : comparison between clipping and coiling" 8 : 260-261, 2006

21 Moon JS, "Computerized Tomographic Findings and Clinical Observations of Cerebrovascular Accidents" 28 : 499-507, 1985

22 Taylor CL, "Complications of preoperative embolization of cerebral arteriovenous malformations" 100 : 810-812, 2004

23 Haw CS, "Complications of embolization of arteriovenous malformations of the brain" 104 : 226-232, 2006

24 Ledezma CJ, "Complications of cerebral arteriovenous malformation embolization: multivariate analysis of predictive factors" 58 : 602-611, 2006

25 Chimowitz MI, "Comparison of wafarin and aspirin for symptomatic intracranial arterial stenosis" 352 : 1305-1316, 2005

26 Neau JP, "Awareness within the French population concerning stroke signs, symptoms, and risk factors" 111 : 659-664, 2009

27 Luessenhop AJ, "Artificial embolization of cerebral arteries. Report of use in a case of arteriovenous malformation" 172 : 1153-1155, 1960

28 Jiang WJ, "Apollo stent for symptomatic atherosclerotic intracranial stenosis: study results" 28 : 830-834, 2007

29 Bose A., "A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenosis: the Wingspan study" 38 : 1531-1537, 2007

30 Song HS, "A Clinical Study on CVA with Brain Scan" 25 : 1348-1358, 1982